EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

COMPARISON OF EFFICACY OF ORAL VERSUS VAGINAL MISOPROSTOL FOR FIRST TRIMESTER MISSED MISCARRIAGES

Dr. Rabia Rehman, Dr. Shumaila Naeem, Dr. Hadia Bashir, Dr. Kausar Masoom, Dr. Najma Khurshid, Dr. Rehana Batool

Genetics and Molecular Research · 07.07.2026

DOI: 10.4238/yjepkq06 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetics and Molecular Research, online erschienen am 07.07.2026. Verfasst von Dr. Rabia Rehman und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Missed miscarriage is a common early pregnancy complication requiring timely and effective management. Misoprostol is widely used for medical treatment, but the optimal route of administration remains debated.

Objective

To compare the efficacy of oral versus vaginal misoprostol in the management of first-trimester missed miscarriage. Methodology: This comparative cross-sectional study was conducted at the Maternity and Child Health Centre, Pakistan Institute of Medical Sciences, from 20-10-2025 to 03-04-2026, including 122 women aged 18–40 years with ultrasound-confirmed missed miscarriage (≤12 weeks gestation), allocated into oral (n=61) and vaginal (n=61) misoprostol groups. Participants received 800 μg misoprostol every 6 hours for a maximum of three doses. Complete expulsion was confirmed by transabdominal ultrasonography 24-hours after passage of pregnancy tissue, defined as endometrial thickness 0.05). Vaginal misoprostol achieved a significantly higher complete expulsion rate than oral misoprostol (91.8% vs. 75.4%, p=0.018). More women in the vaginal group achieved complete expulsion after the first dose (52.5% vs. 29.5%, p=0.031). The vaginal route resulted in a shorter mean time to expulsion (8.3±1.9 vs. 10.4±2.2 hours, p=0.001) and required fewer doses (1.8±0.7 vs. 2.5±0.6, p=0.003). Nausea and vomiting were less frequent with vaginal administration (14% vs. 32%, p=0.011), whereas abdominal pain and fever were comparable (p>0.05). Stratified analyses by age and gestational age showed no significant effect modification (all p>0.05).

Conclusion

Vaginal misoprostol is more effective, faster, and better tolerated than oral misoprostol for first-trimester missed miscarriage, though both remain safe options.

Zitieren

APA

Rehman, D. R., Naeem, D. S., Bashir, D. H., Masoom, D. K., Khurshid, D. N., & Batool, D. R. (2026). COMPARISON OF EFFICACY OF ORAL VERSUS VAGINAL MISOPROSTOL FOR FIRST TRIMESTER MISSED MISCARRIAGES. Genetics and Molecular Research. https://doi.org/10.4238/yjepkq06

Vancouver

Rehman DR, Naeem DS, Bashir DH, Masoom DK, Khurshid DN, Batool DR. COMPARISON OF EFFICACY OF ORAL VERSUS VAGINAL MISOPROSTOL FOR FIRST TRIMESTER MISSED MISCARRIAGES. Genetics and Molecular Research. 2026. doi:10.4238/yjepkq06

BibTeX
@article{Rehman2026,
  author = {Rehman, Dr. Rabia and Naeem, Dr. Shumaila and Bashir, Dr. Hadia and Masoom, Dr. Kausar and Khurshid, Dr. Najma and Batool, Dr. Rehana},
  title = {COMPARISON OF EFFICACY OF ORAL VERSUS VAGINAL MISOPROSTOL FOR FIRST TRIMESTER MISSED MISCARRIAGES},
  journal = {Genetics and Molecular Research},
  year = {2026},
  doi = {10.4238/yjepkq06}
}
Kostenlos starten →